{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T10:21:15Z","timestamp":1793182875375,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T00:00:00Z","timestamp":1646697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T00:00:00Z","timestamp":1646697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Seed Foundation of Peking University First Hospital","award":["No. 2019SF16"],"award-info":[{"award-number":["No. 2019SF16"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81490745"],"award-info":[{"award-number":["81490745"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Major National Scientific Research Program of China","award":["2015CB943304"],"award-info":[{"award-number":["2015CB943304"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Early-onset preeclampsia (EO-PE) and late-onset preeclampsia (LO-PE) are different subtypes of preeclampsia. We conducted this study to analyze the similarities and differences in the clinical features and pregnancy outcomes in EO- and LO-PE with HELLP syndrome.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This was a retrospective study in a tertiary hospital. Eighty-three parturients with HELLP syndrome were allocated into two groups based on the timing of preeclampsia onset: EO-PE with HELLP (<jats:italic>n<\/jats:italic>\u2009=\u200947) and LO-PE with HELLP (<jats:italic>n<\/jats:italic>\u2009=\u200936).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, 31.9% and 63.9% of women in the EO-PE with HELLP and LO-PE with HELLP groups, respectively, were asymptomatic at diagnosis (<jats:italic>P<\/jats:italic>\u2009=\u20090.004, OR\u2009=\u20090.265 (0.106\u20130.662)). Headache or visual symptoms were more frequent in the EO-PE group than in the LO-PE group (48.9% vs. 25%, <jats:italic>P<\/jats:italic>\u2009=\u20090.026, OR\u2009=\u20090.348 (0.135\u20130.896)). Women in the EO-PE with HELLP group had higher SBP and DBP than those in the LO-PE with HELLP group. Laboratory tests, including platelets, liver function, and hemolysis, which are the main indicators for the diagnosis of HELLP syndrome, showed almost no significant differences between the two groups, with kidney function being the only difference observed. Women in the EO-PE with HELLP group had higher Scr than those in the LO-PE with HELLP group. The degree of proteinuria was higher in the EO-PE group than in the LO-PE with HELLP group. The incidence of severe maternal complications was significantly higher in the EO-PE group than in the LO-PE with HELLP group (25.5% vs. 5.6%, <jats:italic>P<\/jats:italic>\u2009=\u20090.016, OR\u2009=\u20090.172 (0.036\u20130.824)). In total, 57.4% and 8.3% of neonates in the EO-PE and LO-PE with HELLP groups were admitted to the NICU, and the difference was statistically significant, even after adjustment for the delivery week (<jats:italic>P<\/jats:italic>\u2009=\u20090.009, OR\u2009=\u20090.830 (0.729\u20130.944)). Postpartum HELLP syndrome was more common in the LO-PE group than in the EO-PE group (30.6% vs. 4.3%, <jats:italic>P<\/jats:italic>\u2009=\u20090.001, OR\u2009=\u20099.9 (2.031\u201348.256)).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Compared with LO-PE with HELLP patients, EO-PE with HELLP patients have more obvious kidney damage, higher blood pressure and a higher risk of adverse maternal and neonatal outcomes. Patients with LO-PE need to be alerted to the occurrence of HELLP syndrome after delivery.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-022-04466-9","type":"journal-article","created":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T11:04:09Z","timestamp":1646737449000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Comparison of clinical features and pregnancy outcomes in early- and late-onset preeclampsia with HELLP syndrome: a 10-year retrospective study from a tertiary hospital and referral center in China"],"prefix":"10.1186","volume":"22","author":[{"given":"Boya","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,8]]},"reference":[{"issue":"10022","key":"4466_CR1","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0140-6736(15)00070-7","volume":"387","author":"BWJ Mol","year":"2016","unstructured":"Mol BWJ, Roberts CT, Thangaratinam S, Magee LA, de Groot CJM, Hofmeyr GJ. Pre-eclampsia. Lancet. 2016;387(10022):999\u20131011. https:\/\/doi.org\/10.1016\/S0140-6736(15)00070-7.","journal-title":"Lancet"},{"issue":"8","key":"4466_CR2","doi-asserted-by":"publisher","first-page":"605","DOI":"10.2471\/BLT.13.127464","volume":"92","author":"S Saleem","year":"2014","unstructured":"Saleem S, McClure EM, Goudar SS, et al. A prospective study of maternal, fetal and neonatal deaths in low- and middle-income countries. Bull World Health Organ. 2014;92(8):605\u201312. https:\/\/doi.org\/10.2471\/BLT.13.127464.","journal-title":"Bull World Health Organ"},{"issue":"2","key":"4466_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1081\/PRG-120021060","volume":"22","author":"P von Dadelszen","year":"2003","unstructured":"von Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens Pregnancy. 2003;22(2):143\u20138. https:\/\/doi.org\/10.1081\/PRG-120021060.","journal-title":"Hypertens Pregnancy"},{"issue":"6","key":"4466_CR4","doi-asserted-by":"publisher","first-page":"544.e1","DOI":"10.1016\/j.ajog.2013.08.019","volume":"209","author":"S Lisonkova","year":"2013","unstructured":"Lisonkova S, Joseph KS. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol. 2013;209(6):544.e1-544.e12. https:\/\/doi.org\/10.1016\/j.ajog.2013.08.019.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"4466_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.preghy.2015.12.003","volume":"6","author":"XL Li","year":"2016","unstructured":"Li XL, Guo PL, Xue Y, Gou WL, Tong M, Chen Q. An analysis of the differences between early and late preeclampsia with severe hypertension. Pregnancy Hypertens. 2016;6(1):47\u201352. https:\/\/doi.org\/10.1016\/j.preghy.2015.12.003.","journal-title":"Pregnancy Hypertens"},{"issue":"2","key":"4466_CR6","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0002-9378(90)90376-i","volume":"162","author":"BM Sibai","year":"1990","unstructured":"Sibai BM. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing? Am J Obstet Gynecol. 1990;162(2):311\u20136. https:\/\/doi.org\/10.1016\/0002-9378(90)90376-i.","journal-title":"Am J Obstet Gynecol"},{"issue":"5 Pt 1","key":"4466_CR7","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1097\/01.AOG.0000126245.35811.2a","volume":"103","author":"BM Sibai","year":"2004","unstructured":"Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol. 2004;103(5 Pt 1):981\u201391. https:\/\/doi.org\/10.1097\/01.AOG.0000126245.35811.2a.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"4466_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/s0002-9378(16)32330-4","volume":"142","author":"L Weinstein","year":"1982","unstructured":"Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol. 1982;142(2):159\u201367. https:\/\/doi.org\/10.1016\/s0002-9378(16)32330-4.","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"4466_CR9","first-page":"721","volume":"50","author":"Hypertensive disorders in pregnancy subgroup CSoO, gynecology CMA, hypertensive disorders in pregnancy subgroup Chinese society of O, gynecology Chinese medical A","year":"2015","unstructured":"Hypertensive disorders in pregnancy subgroup CSoO, gynecology CMA, hypertensive disorders in pregnancy subgroup Chinese society of O, gynecology Chinese medical A. Diagnosis and treatment guideline of hypertensive disorders in pregnancy (2015). Zhonghua Fu Chan Ke Za Zhi. 2015;50(10):721\u20138.","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"4466_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0002-9378(90)90376-I","volume":"162","author":"BM Sibai","year":"1990","unstructured":"Sibai BM. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing? Am J Obstet Gynecol. 1990;162:311\u20136 Level III.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"4466_CR11","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3109\/10641955.2010.507849","volume":"31","author":"G Yildirim","year":"2012","unstructured":"Yildirim G, Gungorduk K, Gul A, et al. HELLP syndrome: 8 years of experience from a tertiary referral center in western Turkey. Hypertens Pregnancy. 2012;31(3):316\u201326. https:\/\/doi.org\/10.3109\/10641955.2010.507849.","journal-title":"Hypertens Pregnancy"},{"issue":"Suppl 1","key":"4466_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1365-3016.2007.00835.x","volume":"21","author":"J Zhang","year":"2007","unstructured":"Zhang J. Partner change, birth interval and risk of pre-eclampsia: a paradoxical triangle. Paediatr Perinat Epidemiol. 2007;21(Suppl 1):31\u20135. https:\/\/doi.org\/10.1111\/j.1365-3016.2007.00835.x.","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"6","key":"4466_CR13","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/aogs.13322","volume":"97","author":"O Malmstr\u00f6m","year":"2018","unstructured":"Malmstr\u00f6m O, Morken NH. HELLP syndrome, risk factors in first and second pregnancy: a population-based cohort study. Acta Obstet Gynecol Scand. 2018;97(6):709\u201316. https:\/\/doi.org\/10.1111\/aogs.13322 (Epub 2018 Mar 25 PMID: 29430625).","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4","key":"4466_CR14","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/0002-9378(93)90043-i","volume":"169","author":"BM Sibai","year":"1993","unstructured":"Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol. 1993;169(4):1000\u20136. https:\/\/doi.org\/10.1016\/0002-9378(93)90043-i.","journal-title":"Am J Obstet Gynecol"},{"issue":"Pt B","key":"4466_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.cca.2015.10.024","volume":"451","author":"LM Dusse","year":"2015","unstructured":"Dusse LM, Alpoim PN, Silva JT, Rios DR, Brand\u00e3o AH, Cabral AC. Revisiting HELLP syndrome. Clin Chim Acta. 2015;451(Pt B):117\u201320. https:\/\/doi.org\/10.1016\/j.cca.2015.10.024.","journal-title":"Clin Chim Acta"},{"key":"4466_CR16","doi-asserted-by":"publisher","unstructured":"Kornacki J, Wirstlein P, Wender-Ozegowska E. Serum levels of soluble FMS-like tyrosine kinase 1 and endothelial glycocalyx components in early- and late-onset preeclampsia. J Matern Fetal Neonatal Med. 2021;1\u20135. Advance online publication. https:\/\/doi.org\/10.1080\/14767058.2021.1949704.","DOI":"10.1080\/14767058.2021.1949704"},{"issue":"4","key":"4466_CR17","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1080\/10641955.2021.1987454","volume":"40","author":"J Kornacki","year":"2021","unstructured":"Kornacki J, Boro\u0144 D, Gutaj P, Mantaj U, Wirstlein P, Wender-Ozegowska E. Diagnosis of preeclampsia in women with diabetic kidney disease. Hypertens Pregnancy. 2021;40(4):322\u20139. https:\/\/doi.org\/10.1080\/10641955.2021.1987454.","journal-title":"Hypertens Pregnancy"},{"issue":"21","key":"4466_CR18","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1080\/14767058.2017.1359528","volume":"31","author":"S Erk\u0131l\u0131n\u00e7","year":"2018","unstructured":"Erk\u0131l\u0131n\u00e7 S, Eyi EGY. Factors contributing to adverse maternal outcomes in patients with HELLP syndrome. J Matern Fetal Neonatal Med. 2018;31(21):2870\u20136. https:\/\/doi.org\/10.1080\/14767058.2017.1359528.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"2","key":"4466_CR19","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/s0002-9378(96)70162-x","volume":"175","author":"F Audibert","year":"1996","unstructured":"Audibert F, Friedman SA, Frangieh AY, Sibai BM. Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol. 1996;175(2):460\u20134. https:\/\/doi.org\/10.1016\/s0002-9378(96)70162-x.","journal-title":"Am J Obstet Gynecol"},{"key":"4466_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.preghy.2017.09.003","volume":"12","author":"TH Hung","year":"2018","unstructured":"Hung TH, Hsieh TT, Chen SF. Risk of abnormal fetal growth in women with early- and late-onset preeclampsia. Pregnancy Hypertens. 2018;12:201\u20136. https:\/\/doi.org\/10.1016\/j.preghy.2017.09.003.","journal-title":"Pregnancy Hypertens"},{"issue":"6","key":"4466_CR21","first-page":"361","volume":"22","author":"Fetal Medicine Subgroup,Society of Perintal Medicine","year":"2019","unstructured":"Fetal Medicine Subgroup,Society of Perintal Medicine, Chinese Medical Association and Obstetrics Subgroup, Society of Obstetrics and Gynecology, Chinese Medical Association. Expert consensus on fetal growth restriction. Zhonghua Fu Chan Ke Za Zhi. 2019;22(6):361\u201380.","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"4","key":"4466_CR22","doi-asserted-by":"publisher","first-page":"449.e1","DOI":"10.1016\/j.ajog.2015.08.032","volume":"213","author":"GM Buck Louis","year":"2015","unstructured":"Buck Louis GM, Grewal J, Albert PS, et al. Racial\/ethnic standards for fetal growth: the NICHD Fetal Growth Studies. Am J Obstet Gynecol. 2015;213(4):449.e1-449.e41. https:\/\/doi.org\/10.1016\/j.ajog.2015.08.032.","journal-title":"Am J Obstet Gynecol"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-022-04466-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-022-04466-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-022-04466-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T11:06:18Z","timestamp":1646737578000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-022-04466-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,8]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4466"],"URL":"https:\/\/doi.org\/10.1186\/s12884-022-04466-9","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,8]]},"assertion":[{"value":"3 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the Declaration of Helsinki and was reviewed and approved by the Ethics committee of Peking University First Hospital (Reference Number: 2020 research 434).The Ethics committee of Peking University First Hospital approved informed consent waiver for this study due to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"186"}}